Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$75.21 USD
+0.43 (0.58%)
Updated May 3, 2024 04:00 PM ET
After-Market: $75.24 +0.03 (0.04%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/7/24 |
---|---|
Current Quarter | 0.86 |
EPS Last Quarter | 0.99 |
Last EPS Surprise | 13.79% |
ABR | 2.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 3.96 |
Next Year | 4.12 |
EPS (TTM) | 3.79 |
P/E (F1) | 18.24 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 825.20M | 861.68M | 3.34B | 3.51B |
# of Estimates | 1 | 1 | 2 | 2 |
High Estimate | 825.20M | 861.68M | 3.34B | 3.51B |
Low Estimate | 825.20M | 861.68M | 3.33B | 3.51B |
Year ago Sales | 766.00M | 820.20M | 3.02B | 3.34B |
Year over Year Growth Est. | 7.73% | 5.06% | 10.52% | 5.23% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.86 | 1.10 | 3.96 | 4.12 |
# of Estimates | 1 | 1 | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.86 | 1.10 | 3.99 | 4.18 |
Low Estimate | 0.86 | 1.10 | 3.95 | 4.09 |
Year ago EPS | 0.70 | 1.03 | 3.30 | 3.96 |
Year over Year Growth Est. | 22.86% | 6.80% | 20.00% | 4.04% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Current | 0.86 | 1.10 | 3.96 | 4.12 |
7 Days Ago | 0.86 | 1.10 | 3.96 | 4.12 |
30 Days Ago | 0.86 | 1.10 | 3.96 | 4.12 |
60 Days Ago | 0.86 | 1.10 | 3.96 | 4.12 |
90 Days Ago | 0.86 | 1.10 | 3.92 | 4.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.86 | 1.10 | 3.96 | 4.12 |
Zacks Consensus Estimate | 0.86 | 1.10 | 3.96 | 4.12 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.99 | 1.07 | 1.03 | 0.70 | NA |
Estimate | 0.87 | 0.88 | 0.71 | 0.57 | NA |
Difference | 0.12 | 0.19 | 0.32 | 0.13 | 0.19 |
Surprise | 13.79% | 21.59% | 45.07% | 22.81% | 25.82% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more